U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06856954) titled 'The Skin Barrier in Users of Diabetes Devices' on Feb. 26.
Brief Summary: Diabetes technology (insulin pumps and continuous glucose monitoring) have become standard of care in children with type 1 diabetes. Unfortunately, the attachment of the devices to the skin can provoke injury, irritative or allergic eczema of the skin. Additionally, the continuous insulin infusion often causes sub-cutaneous lipohypertrophy. These occurrences are likely to increase blood glucose fluctuation and impact burden of diabetes. In collaboration with dermatologists, we propose to investigate the skin microcirculation and skin barrier as well as the sub...